<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical development of ATMP encounters specific challenges due to the nature of the product and the limited availability of non-clinical data. In addition, their mode of administration may be invasive or require special equipment to place them in the human body, a procedure which raises additional quality assurance problems associated with the administration process (
 <xref rid="T2" ref-type="table">Table 2</xref>).
</p>
